2月24日,兴齐眼药旗下0.02%浓度硫酸阿托品滴眼液在京东健康线上首发,0.04%浓度也将在近期于平台上线。该药适用于延缓4至16岁儿童的近视进展[1],与此前获批的0.01%浓度共同形成阶梯式多浓度矩阵。京东健康将充分发挥"新特药全网首发第一站"能力优势,提升这款新药的可及性,为近视儿童提供个性化解决方案。根据国家疾控局监测数据显示,2022年我国儿童青少年总体近视率为51.9%,其中小学生达...
Source Link2月24日,兴齐眼药旗下0.02%浓度硫酸阿托品滴眼液在京东健康线上首发,0.04%浓度也将在近期于平台上线。该药适用于延缓4至16岁儿童的近视进展[1],与此前获批的0.01%浓度共同形成阶梯式多浓度矩阵。京东健康将充分发挥"新特药全网首发第一站"能力优势,提升这款新药的可及性,为近视儿童提供个性化解决方案。根据国家疾控局监测数据显示,2022年我国儿童青少年总体近视率为51.9%,其中小学生达...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.